
Friday, August 24, 2007 12:38:04 PM
MGRM Monogram Biosciences' oncology franchise will garner increased attention in 2H07 - Lazard (1.68 +0.01)
Lazard says that following maraviroc's FDA approval and tropism testing mentioned on the label, all that is left for current HIV catalysts are the sales execution of maraviroc and Trofile. Firm believes MGRM's oncology franchise will garner increased attention in 2H07. Following the positive early data that was presented at A.S.C.O in June, firm looks forward to upcoming oncology assay catalysts: 1) additional VeraTag data, 2) scientific journal publications, and 3) corporate oncology partner announced. They believe MGRM's opportunity to secure oncology collaborations should surpass those it has in HIV.
Rate it:
awful/not related to \pooraveragegoodexcellent
bullcall56
View Messages
Ignore User
Report A
Change is the only constant
Recent MGRM News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2024 09:00:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2024 01:35:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/02/2024 09:13:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2024 01:52:37 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 09:33:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 09:07:08 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/08/2024 03:00:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/30/2024 07:18:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 09:05:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 01:28:37 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/02/2024 09:23:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 09:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 01:35:28 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/11/2024 09:26:27 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/17/2024 08:51:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 10:30:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 01:20:40 PM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 05/08/2024 08:55:25 PM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM
VAYK Project $700K 2024 Revenue with $150K Net Profit • VAYK • Feb 5, 2025 12:43 PM
UAV Corp (UMAV) Kicks Off Landmark "SKY" Hangar Project with Land Clearing at Costin Airport Setting Stage for Q1 2025 Groundbreaking • UMAV • Feb 5, 2025 8:30 AM
HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future • HLYK • Feb 4, 2025 8:00 AM
Wytec Wins Multi-State Government Contract for AI Gunshot Detection • WYTC • Feb 3, 2025 7:16 AM
UAV Corp. Retains Legal Counsel to Address Legacy Debt from HTTI Era; 500 Million Authorized Shares Confirmed - UAV Corp. Delivers on Strategic Commitments • UMAV • Jan 31, 2025 1:30 PM